First Wave BioPharma, Inc. (FWBI) Financials

NASDAQ Currency in USD Disclaimer

$2.96

north_east NA Past Year
Day's range
$2.84
Day's range
$3.04

FWBI Income statement / Annual

Last year (2023), First Wave BioPharma, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, First Wave BioPharma, Inc.'s net income was -$15.79 M. See First Wave BioPharma, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $29,274.00 $106,207.00 $537,400.00 $571,145.00 $976,982.00 $0.00 $0.00 $0.00 $0.00
Gross Profit -$29,274.00 -$106,207.00 -$537,400.00 -$571,145.00 -$976,982.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0 0 0 0 0 0
Research and Development Expenses $5.03 M $691,257.00 $38.32 M $19.14 M $8.68 M $4.99 M $2.40 M $2.50 M $1.40 M
General & Administrative Expenses $10.74 M $11.99 M $18.38 M $7.29 M $6.06 M $8.24 M $0.00 $0.00 $0.00
Selling & Marketing Expenses -$29,274.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $10.71 M $11.99 M $18.38 M $7.29 M $6.06 M $8.24 M $7.69 M $4.13 M $3.33 M
Other Expenses $0.00 -$232,741.00 $529,101.00 $211,430.00 $0.00 -$210,000.00 $0.00 $0.00 $0.00
Operating Expenses $15.74 M $12.68 M $56.70 M $26.43 M $14.74 M $13.43 M $10.08 M $6.63 M $4.73 M
Cost And Expenses $15.77 M $12.68 M $56.70 M $26.43 M $14.74 M $13.43 M $10.08 M $6.63 M $4.73 M
Interest Income $19,932.00 $8,415.00 $1,173.00 $484.00 $433.94 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $15,879.00 $11,235.00 $5.84 M $433,939.00 $101,846.00 $875,199.00 $5.94 M $1.59 M
Depreciation & Amortization $29,274.00 -$195,055.00 $3.42 M $777,259.00 $1.02 M $798,446.00 $753,998.00 $734,500.00 $733,599.00
EBITDA -$15.74 M -$12.87 M -$55.63 M -$25.66 M -$13.72 M -$12.63 M -$9.33 M -$5.89 M -$4.00 M
EBITDA Ratio 0 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net -$24,153.00 -$1.95 M -$1.83 M -$6.24 M -$433,939.00 -$311,846.00 -$875,199.00 -$8.27 M -$1.20 M
Income Before Tax -$15.79 M -$14.63 M -$58.54 M -$32.67 M -$15.18 M -$13.53 M -$11.10 M -$14.59 M -$5.93 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0
Income Tax Expense -$4.00 $1.95 M $540,336.00 $6.05 M $433,939.00 -$108,154.00 $875,199.00 $5.94 M $1.59 M
Net Income -$15.79 M -$16.58 M -$59.08 M -$38.72 M -$15.61 M -$13.53 M -$11.10 M -$14.59 M -$5.93 M
Net Income Ratio 0 0 0 0 0 0 0 0 0
EPS -46.96 -461.72 -27799.23 -57194.08 -29238.43 -1840.81 -2192.53 -4711.55 -1293.12
EPS Diluted -46.96 -461.72 -27799.23 -57194.08 -29238.43 -1840.81 -2192.53 -4711.55 -1261.75
Weighted Average Shares Out $336,342.00 $35,912.00 $2,125.17 $677.05 $533.94 $7,352.00 $5,061.00 $3,097.00 $4,586.00
Weighted Average Shares Out Diluted $336,342.00 $35,912.00 $2,125.17 $677.05 $533.94 $7,352.00 $5,061.00 $3,097.00 $4,700.00
Link